Skip to content
Screener

Common Stock at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
200M0.0%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$6K0.0%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
250M0.0%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$79K+19.7%
Alumis Inc. logo
Alumis Inc.ALMS
$1K
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
390M+30.0%

Other financials

Income statement

See full
Revenue$700.0K-53.3%
Operating income-$50.6M-23.1%
Net income-$50.4M-20.3%
EPS (diluted)-$0.12+61.3%

Balance sheet

See full
Cash & equivalents$174.9M+69.5%
Total debt$7.7M+0.1%
Total equity$160.4M+86.1%
Total assets$223.2M+55.6%

Cash flow

See full
Operating cash flow-$52.6M-55.2%
CapEx$400.0K
Free cash flow-$53.0M-56.3%

Valuation

See full
Market cap$847.16M+218%
Enterprise value$679.96M+297%
P/S168.8×+100×

Profitability

See full
Operating margin-3,543.1%+523pp
Net margin-3,506.5%+442pp
FCF margin-3,399.3%+3,268pp

Returns & leverage

See full
Return on equity-142.7%-5.0pp
Debt / equity0.0×
Current ratio3.7×+1.3×

Where this comes from

Reported directly by DBV Technologies in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The source filing: DBV Technologies’s 10-Q, filed July 16, 2026.

Filed
Jul 16, 2026, 4:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-048453

The share capital as of June 30, 2026 is set at the sum of €29,606,149.70 ($33,961,702.00 converted at historical rates). It is divided into 296,061,497 fully authorized, subscribed and paid-up ordinary shares with a par value of €0.10.

Item 1C. Condensed Consolidated Statements of Financial Position (Unaudited) as of

FAQ

What is DBV Technologies's common stock?
DBV Technologies (DBVT) reported common stock of $29.61M in Q2 2026.
How has DBV Technologies's common stock changed year-over-year?
DBV Technologies's common stock increased by 187.8% year-over-year, from $10.29M to $29.61M.
What is the long-term trend for DBV Technologies's common stock?
Over 5 years (2020 to 2025), DBV Technologies's common stock has grown at a 32.8% compound annual growth rate (CAGR), from $6.52M to $26.91M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about DBV Technologies's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude